On Thursday, United State’s company Merck has their antiviral medication used to treat COVID-19 approved in the United Kingdom.
The pill was approved in an attempt to fight the outbreak currently happening throughout the country.
The drug, molnupiravir, was suggested to be used for those with mild to moderate cases of COVID-19 with one risk factor that could cause issues like obesity or diabetes.
The drug will be given to a person after they test positive within 5 days of showing symptoms.
The U.S. will consider approving the drug next month.
The former commissioner of the FDA, Dr. Scott Gottlieb, said the pill could get society out of the pandemic phase of the outbreak.
Related: Merck applies for FDA emergency use authorization for its COVID-19 pill
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.


